These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1189 related items for PubMed ID: 26764184

  • 41. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
    Liu J, Yang P, Zuo G, He S, Tan W, Zhang X, Su C, Zhao L, Wei L, Chen Y, Ruan X, Chen Y.
    Lipids Health Dis; 2018 Jul 17; 17(1):153. PubMed ID: 30016988
    [Abstract] [Full Text] [Related]

  • 42. Rho-kinase-dependent pathway mediates the hepatoprotective effects of sorafenib against ischemia/reperfusion liver injury in rats with nonalcoholic steatohepatitis.
    Yang YY, Huang YT, Lee TY, Chan CC, Yeh YC, Lee KC, Lin HC.
    Liver Transpl; 2012 Nov 17; 18(11):1371-83. PubMed ID: 22847887
    [Abstract] [Full Text] [Related]

  • 43. Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update.
    Dorairaj V, Sulaiman SA, Abu N, Abdul Murad NA.
    Biomolecules; 2020 Oct 30; 10(11):. PubMed ID: 33143043
    [Abstract] [Full Text] [Related]

  • 44. Lipotoxic hepatocytes promote nonalcoholic fatty liver disease progression by delivering microRNA-9-5p and activating macrophages.
    Liu H, Niu Q, Wang T, Dong H, Bian C.
    Int J Biol Sci; 2021 Oct 30; 17(14):3745-3759. PubMed ID: 35261562
    [Abstract] [Full Text] [Related]

  • 45. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
    Zou A, Magee N, Deng F, Lehn S, Zhong C, Zhang Y.
    J Biol Chem; 2018 Jun 01; 293(22):8656-8671. PubMed ID: 29666185
    [Abstract] [Full Text] [Related]

  • 46. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
    Di Mauro S, Ragusa M, Urbano F, Filippello A, Di Pino A, Scamporrino A, Pulvirenti A, Ferro A, Rabuazzo AM, Purrello M, Purrello F, Piro S.
    Nutr Metab Cardiovasc Dis; 2016 Dec 01; 26(12):1129-1139. PubMed ID: 27756518
    [Abstract] [Full Text] [Related]

  • 47. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
    Afonso MB, Rodrigues PM, Carvalho T, Caridade M, Borralho P, Cortez-Pinto H, Castro RE, Rodrigues CM.
    Clin Sci (Lond); 2015 Oct 01; 129(8):721-39. PubMed ID: 26201023
    [Abstract] [Full Text] [Related]

  • 48. Polydatin attenuates diet-induced nonalcoholic steatohepatitis and fibrosis in mice.
    Li R, Li J, Huang Y, Li H, Yan S, Lin J, Chen Y, Wu L, Liu B, Wang G, Lan T.
    Int J Biol Sci; 2018 Oct 01; 14(11):1411-1425. PubMed ID: 30262993
    [Abstract] [Full Text] [Related]

  • 49. Comprehensive characterization of hepatocyte-derived extracellular vesicles identifies direct miRNA-based regulation of hepatic stellate cells and DAMP-based hepatic macrophage IL-1β and IL-17 upregulation in alcoholic hepatitis mice.
    Eguchi A, Yan R, Pan SQ, Wu R, Kim J, Chen Y, Ansong C, Smith RD, Tempaku M, Ohno-Machado L, Takei Y, Feldstein AE, Tsukamoto H.
    J Mol Med (Berl); 2020 Jul 01; 98(7):1021-1034. PubMed ID: 32556367
    [Abstract] [Full Text] [Related]

  • 50. Gallic Acid Inhibits Lipid Accumulation via AMPK Pathway and Suppresses Apoptosis and Macrophage-Mediated Inflammation in Hepatocytes.
    Tanaka M, Sato A, Kishimoto Y, Mabashi-Asazuma H, Kondo K, Iida K.
    Nutrients; 2020 May 20; 12(5):. PubMed ID: 32443660
    [Abstract] [Full Text] [Related]

  • 51. Targeting alkaline ceramidase 3 alleviates the severity of nonalcoholic steatohepatitis by reducing oxidative stress.
    Wang K, Li C, Lin X, Sun H, Xu R, Li Q, Wei Y, Li Y, Qian J, Liu C, Zhang Q, Yu S, Cui Z, Huang X, Zhu B, Zhou J, Mao C.
    Cell Death Dis; 2020 Jan 16; 11(1):28. PubMed ID: 31949129
    [Abstract] [Full Text] [Related]

  • 52. Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis.
    He Y, Rodrigues RM, Wang X, Seo W, Ma J, Hwang S, Fu Y, Trojnár E, Mátyás C, Zhao S, Ren R, Feng D, Pacher P, Kunos G, Gao B.
    J Clin Invest; 2021 Feb 01; 131(3):. PubMed ID: 33301423
    [Abstract] [Full Text] [Related]

  • 53. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
    Chong LW, Hsu YC, Lee TF, Lin Y, Chiu YT, Yang KC, Wu JC, Huang YT.
    BMC Gastroenterol; 2015 Feb 15; 15():22. PubMed ID: 25886887
    [Abstract] [Full Text] [Related]

  • 54. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
    Li S, Li X, Chen F, Liu M, Ning L, Yan Y, Zhang S, Huang S, Tu C.
    J Nutr Biochem; 2022 Feb 15; 100():108888. PubMed ID: 34695558
    [Abstract] [Full Text] [Related]

  • 55. A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis.
    Jin K, Shi Y, Zhang H, Zhangyuan G, Wang F, Li S, Chen C, Zhang J, Wang H, Zhang W, Sun B.
    J Hepatol; 2023 Aug 15; 79(2):403-416. PubMed ID: 37040844
    [Abstract] [Full Text] [Related]

  • 56. Palmitic acid induces autophagy in hepatocytes via JNK2 activation.
    Tu QQ, Zheng RY, Li J, Hu L, Chang YX, Li L, Li MH, Wang RY, Huang DD, Wu MC, Hu HP, Chen L, Wang HY.
    Acta Pharmacol Sin; 2014 Apr 15; 35(4):504-12. PubMed ID: 24608675
    [Abstract] [Full Text] [Related]

  • 57. Lipotoxic Hepatocyte-Derived Exosomal MicroRNA 192-5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease.
    Liu XL, Pan Q, Cao HX, Xin FZ, Zhao ZH, Yang RX, Zeng J, Zhou H, Fan JG.
    Hepatology; 2020 Aug 15; 72(2):454-469. PubMed ID: 31782176
    [Abstract] [Full Text] [Related]

  • 58. Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice.
    Lebeaupin C, Vallée D, Rousseau D, Patouraux S, Bonnafous S, Adam G, Luciano F, Luci C, Anty R, Iannelli A, Marchetti S, Kroemer G, Lacas-Gervais S, Tran A, Gual P, Bailly-Maitre B.
    Hepatology; 2018 Aug 15; 68(2):515-532. PubMed ID: 29457838
    [Abstract] [Full Text] [Related]

  • 59. Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
    Pourcet B, Zecchin M, Ferri L, Beauchamp J, Sitaula S, Billon C, Delhaye S, Vanhoutte J, Mayeuf-Louchart A, Thorel Q, Haas JT, Eeckhoute J, Dombrowicz D, Duhem C, Boulinguiez A, Lancel S, Sebti Y, Burris TP, Staels B, Duez HM.
    Gastroenterology; 2018 Apr 15; 154(5):1449-1464.e20. PubMed ID: 29277561
    [Abstract] [Full Text] [Related]

  • 60. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation.
    Ibrahim SH, Hirsova P, Gores GJ.
    Gut; 2018 May 15; 67(5):963-972. PubMed ID: 29367207
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 60.